[1] Waksman R, Rodriguez Y.Effect of intravascular ir-radiation on cell proliferation, apoptosis, and vascular remodelling after balloon overstretch injury of porcine coronary arteries[J].Circulation, 1997, 96:1944-1952.
[2] Hehrlein C, Kovacs A.A novel balloon angioplasty catheter impregnated with beta-particle emitting ra-dioisotopes for vascular brachytherapy to prevent restenosis[J].Eur Heart J, 2000, 21(24):2056-2062.
[3] Liermann DD, Bauernsachs R.Five year follow-up af-ter brachytherapy for restenosis in peripheral arteries[J].Semin Interv Cardiol, 1997, 2(2):133-137.
[4] Verin V, popowski Y.Intraarterial beta irradiationin-duces smooth muscle cell apoptosis and reduces medialcel lularity in a hypercholesterolemic rabbit restenosis model[J].Int J Radiat Oncol Biol Phys, 2000, 46(3):661-670.
[5] Verin V, Urban P.Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty[J].Circulation, 1997, 95(5):1138-1144.
[6] Hehrlein C.Low-dose radiactive endovascular stents prevent smooth muscle cell proliferation and neointi-mal hyperplasiain rabbits[J].Circulation, 1995, 92(6):1570-1575.
[7] Hehrlein C.Pure beta-particle-emitting stents inhibit, neiintima formation in rabbits[J].Circulation, 1996, 93(4):641-645.
[8] Farb A, Tang AL, Virmani R, et, al.Neointima is re-duced but endothelialization is incomplete 3 months after 32P beta-emitting stent placement[J].Circulation, 1998, 98:I-779.
[9] Taylor AJ, Gorman PD.Differential effect of 32P beta particle-emitting stents on the neointima and adventitia in the dog model[J].Circulation, 1998, 98:I-779.
[10] Mazur W.High dose rate intracoronary radiation for inhibition of neointima formation in the stented and balloon-injured porcine model of restenosis:angio-graphic, morphomitric, and histopathologic analyses[J].Int J Radiat Oncol Biol Phys, 1996, 36:777-788.
[11] Condado.Three year clinical and angiographic follow-up after ICRT with 192Ir[J].Circulation, 1998, I-abstr.
[12] Waksman R, White LR, Chan RC, et al.Intracoro-nary γ-radiation therapy after angioplasty inhibits re-currence in patients with in-stent restenosis[J].Circulation 2000, 101:2165-2171.
[13] Waksman R, Porrazo MS, Chan RC, et al.Results from the ARTISTIC feasibility study of 192Ir gammaradiation to prevent recurrence of In-stent restenosis[J].Circulation, 1998, 98:I-442.
[14] Akiyama T, Moussa I, Reimers B, et al.Angiograph-ic and clinical outcome following coronary stenting ofsmall coronary stenting of small vessles:a compari-sion with coronary stenting of large vessles[J].J Am Coll Cardial, 1998, 32:1610-1618.
[15] Verin V, Urban P, Popowski Y, et al.Feasibility of intracoronary beta-irradiation to reduce restenosis af-ter balloon angioplasty:a clinical pilot study[J].Cir-culation, 1997, 95:1138-1144.
[16] King SBIII, Crocker IR, Waksman R, et al.Coro-nary endovascular beta-radiation for restenosis using anovel catheter system:initial clinical feasibility study[J].Circulation, 1996, 94(supplⅠ):I-619.
[17] King SB.Endovascular beta radiation to reduce restenosis after coronary balloon angioplasty:results of the beta energy restenosis trial (BERT)[J].Circu-lation, 1998, 97:2025-2030.
[18] Sirnes PA, Golf S, Myreng Y, et al.Sustained benefit of stenting chronic coronary occlusion:long-term clin-ical follow-up of the Stenting in Chronic Coronary Oc-clusion (SICCO) study[J].J Am Coll Cardiol, 1998, 32(2):305-310.
[19] Silber S, von Rottkay P, Lossl P, et al.Safety and feasibility of intracoronary brachytherapy with the Novoste system within the scope of international mul-ticenter studies[J].Z Kardiol, 2000, 89(4):323-329.
[20] Raizner AE, Oesterle S, Waksman R, et al.The PRE-VENT trial, a feasibility study of intracoronary brachytherapy in the prevention of restenosis:an in-terim report[J].Circulation, 1998, 98:I-651.
[21] Coen V L, Knook AH, Wardeh AJ, et al.Endovascu-lar brachytherapy in coronary arteries:the Rotlerdam experience[J].Cardiovasc Radiat Med, 2000, 2(1):42-50.
[22] Mews GC, Fox R, Cope G, et al.Rhenium 188 liquid filled balloon for the treatment of intracoronary in-stent restenosis:a 26 patient pilot study[J].Cardio-vasc Rad Ther Ⅲ.Washington DC, 1999, 23(abstr).
[23] Albiero R, Colombo A.European high-activity 32P ra-dioactive stent experience[J].J Invasive Cardiol, 2000, 12(8):416-421.
[24] Albiero R, Adamian M.Results of the Milan BX dose response study on 32P radioactive beta-emitting stent implantation in patients with CAD[J].Cardiovasc Rad TherⅢ, Washington DC, 1999:391-392.